The Investigators Meeting was jointly organised by ImmuPharma and Simbec-Orion, its development partner for Lupuzor brought together over 70 Lupus Specialists who will be actively involved in the pivotal Phase III clinical trials for Lupuzor involved about the protocol and the required procedures to assess efficacy in the Lupus trial. This will provide consistency across the trial sites and make sure the clinical practitioners are all working towards the same goals and objectives.
